Instil Bio Inc
Research Instil Bio Inc (TIL) on Bullrun: market cap USD 51.54M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTIL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 51.54M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 4.20M
- Free cash flow-USD 43.76M
Valuation Snapshot
latest market cap is USD 51.54M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 71.37M | -USD 46.62M | n/a | -10.7 | USD 6.64M | USD 85.18M | USD 113.87M |
| FY2024 | USD 0 | -USD 74.14M | -USD 55.70M | n/a | -11.39 | USD 8.81M | USD 86.89M | USD 169.44M |
| FY2023 | n/a | -USD 156.09M | -USD 102.69M | n/a | -24 | USD 9.20M | USD 86.05M | USD 225.83M |
| FY2022 | n/a | -USD 223.18M | -USD 264.75M | n/a | -34.46 | USD 43.72M | USD 57.13M | USD 363.61M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 51.54M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 74.60M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 124.58M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 49.56M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 81.76M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.21B | n/a | n/a | n/a |
About Instil Bio Inc
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Instil Bio Inc's market cap?
Instil Bio Inc's market capitalization is USD 51.54M.
What does Instil Bio Inc do?
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.